An Interest In:
Web News this Week
- March 30, 2024
- March 29, 2024
- March 28, 2024
- March 27, 2024
- March 26, 2024
- March 25, 2024
- March 24, 2024
Some of Our Sources
- Technology Review
- Pearsonified
- The Logo Smith
- Smashing Magazine
- Creative Curio
- Reencoded
- 24 Ways
- Specky Boy
- Dev To
- Hashedout
Help Webnuz
Referal links:
December 21, 2011 10:34 pm GMT
Omada Health, a graduate of Rock Health's first batch of startups, is announcing today that it has raised $800K in seed funding from a number of angel and venture investors, including Esther Dyson, NEA, Aberdare, Kapor Capital, and TriplePoint Ventures to name a few.Omada Health, simply put, has turned its focus to one of the most pervasive diseases in the country: Diabetes. Well, really, prediabetes. The CDC estimates that 79 million people in the U.S. currently have prediabetes -- said another way, that's approximately 1 in 3 adults. And the majority of those people are not aware of their condition, which essentially means that they are suffering from blood glucose levels that are not irregular enough to be considered diabetes, yet still indicate an extremely high risk of progressing to full-blown diabetes.
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/0eIsHYweMyw/
Omada Health Raises $850K From Esther Dyson & More To Take On Diabetes
Omada Health, a graduate of Rock Health's first batch of startups, is announcing today that it has raised $800K in seed funding from a number of angel and venture investors, including Esther Dyson, NEA, Aberdare, Kapor Capital, and TriplePoint Ventures to name a few.Omada Health, simply put, has turned its focus to one of the most pervasive diseases in the country: Diabetes. Well, really, prediabetes. The CDC estimates that 79 million people in the U.S. currently have prediabetes -- said another way, that's approximately 1 in 3 adults. And the majority of those people are not aware of their condition, which essentially means that they are suffering from blood glucose levels that are not irregular enough to be considered diabetes, yet still indicate an extremely high risk of progressing to full-blown diabetes.Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/0eIsHYweMyw/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch